Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson's disease

被引:4
作者
Nabizadeh, Fardin [1 ,2 ]
Sodeifian, Fatemeh [3 ]
Pirahesh, Kasra [4 ]
机构
[1] Universal Sci Educ & Res Network USERN, Neurosci Res Grp NRG, Tehran, Iran
[2] Iran Univ Med Sci, Sch Med, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Med, Student Res Comm, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
关键词
Parkinson's disease; Olfactory dysfunction; Dopamine uptake; TREMOR DOMINANT; BIOMARKER;
D O I
10.1007/s10072-022-06110-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Olfactory dysfunction is one of the earliest non-motor symptoms (NMS) in Parkinson's disease (PD). There are contradictory results regarding the association of olfactory dysfunction and dopamine uptake in striatal nuclei among PD patients. It has been suggested that different motor subtypes of PD vary in the disease pathophysiology and progression. Thus, we hypothesized that there might be different associations between olfactory dysfunction and striatal dopaminergic neuronal loss among three motor subtypes of PD, namely, indeterminate, postural instability and gait difficulty (PIGD), and tremor-dominant (TD). Methods We recruited 162 healthy controls (HCs) and 464 drug-naive PD patients from PPMI who underwent common PD scaling tests. Striatal binding ratios (SBRs) of DaTSCAN images in caudate and putamen nuclei were calculated. To assess the olfactory function, the University of Pennsylvania Smell Identification Test (UPSIT) was carried out. Results The UPSIT score was significantly correlated with MDS-UPDRS part I (p value: 0.002, correlation coefficient: - 0.160), MDS-UPDRS part III (p value: 0.000, correlation coefficient: - 0.248), and SBR score in right (p value: 0.000, correlation coefficient: 0.240) and left caudate (p value: 0.000, correlation coefficient: 0.221) and right (p value: 0.000, correlation coefficient: 0.323) and left putamen (p value: 0.000, correlation coefficient: 0.335) nucleus in TD subtype. There were no significant correlations in HC, PIGD, and indeterminate subjects. Conclusion The olfactory dysfunction was correlated with dopamine transporter activity in striatal nuclei only in the TD subtype. Therefore, the olfactory dysfunction in PIGD and indeterminate subtype may not be a predictive factor for the future decrease in dopamine uptake.
引用
收藏
页码:4745 / 4752
页数:8
相关论文
共 40 条
[1]   Diagnosis and Treatment of Parkinson Disease A Review [J].
Armstrong, Melissa J. ;
Okun, Michael S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (06) :548-560
[2]   Development of parkinsonism after long-standing cervical dystonia-A cohort [J].
Balint, Bettina ;
Mulroy, Eoin ;
Goevert, Felix ;
Latorre, Anna ;
Di Lazarro, Giulia ;
Erro, Roberto ;
Batla, Amit ;
Holton, Janice L. ;
Miki, Yasuo ;
Warner, Thomas T. ;
Bhatia, Kailash P. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 427
[3]  
Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7
[4]   Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease [J].
Berendse, Henk W. ;
Roos, Dareia S. ;
Raijmakers, Pieter ;
Doty, Richard L. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) :21-24
[5]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[6]  
Daalen JMJ, 2021, PARKINSONISM RELATED
[7]   Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease [J].
De Pablo-Fernandez, Eduardo ;
Lees, Andrew J. ;
Holton, Janice L. ;
Warner, Thomas T. .
JAMA NEUROLOGY, 2019, 76 (04) :470-479
[8]   Neuropathology of Parkinson disease [J].
Dickson, Dennis W. .
PARKINSONISM & RELATED DISORDERS, 2018, 46 :S30-S33
[9]   Odor Recognition Memory in Parkinson's Disease: A Systematic Review [J].
Eek, Tom ;
Larsson, Maria ;
Dizdar, Nil .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[10]   Biomarker-Driven Phenotyping in Parkinson's Disease: A Translational Missing Link in Disease-Modifying Clinical Trials [J].
Espay, Alberto J. ;
Schwarzschild, Michael A. ;
Tanner, Caroline M. ;
Fernandez, Hubert H. ;
Simon, David K. ;
Leverenz, James B. ;
Merola, Aristide ;
Chen-Plotkin, Alice ;
Brundin, Patrik ;
Kauffman, Marcelo A. ;
Erro, Roberto ;
Kieburtz, Karl ;
Woo, Daniel ;
Macklin, Eric A. ;
Standaert, David G. ;
Lang, Anthony E. .
MOVEMENT DISORDERS, 2017, 32 (03) :319-324